Blackstone Life Sciences
Venture Capital
Part of Blackstone
Blackstone's life sciences investment platform funding late-stage pharmaceutical and biotechnology product development globally.
Growth
Late Stage
Biotech
Healthcare
- Headquarters
- New York, United States
- Founded
- 2018
- Website
- blackstone.com
- AUM
- $15.0B
- Total Investments
- 3
- Last Investment
- Feb 2026
- Geographic Focus
- Europe, Global, United States
Investment Thesis
Partners with leading pharma and biotech companies to co-fund late-stage product development, capturing value via royalties and equity rather than public market exposure.
Investment History
Sign up to view investment history
Create a free account to see deal history, investment amounts, and round details.
Create Free Account